Skip to content
Aurelia

Why we start with less

On dosing below the typical amount, and why the two-week review is where the real decision is made.

  • 14 September 2026Practice
  • 1 min readFrom word count
  • Dosed in units, not syringesExpands the principle
  • Dr Helena MarloweAuthor
A hand writing notes in a spiral notebook with a pen, shallow focus.

Most first injectable treatments here begin at roughly two-thirds of a typical dose. It surprises people, particularly those who have been treated elsewhere and expected to leave with the full effect.

The reason is simple. A face is easier to add to than to take away from. Neuromodulators take around fourteen days to reach their full effect, and until then nobody — patient or doctor — can see the finished result. Treating to the full amount on day one means committing to a result before it exists.

What the review is for

At two weeks, we photograph you under the same light and from the same angles as before, and look at the face moving: frowning, smiling, raising the brows. Most of the time the result is already right. Sometimes one area needs a little more. Occasionally the answer is that it needs nothing at all.

The review is not a follow-up. It is the second half of the treatment.

Because the same doctor treats and reviews, the second appointment starts where the first left off — with the original plan, the original photographs, and an exact record of what was placed where.

What it costs you

  • A second visit, usually short.
  • A fortnight of patience while the result settles.
  • In exchange, a result built to fit rather than corrected afterwards.

Starting with less is not caution for its own sake. It is the most reliable way we know to arrive at a face that looks rested, and still entirely like yours.

More from the journal

Begin with a conversation.

Consultations last forty-five minutes, are held with the doctor who would treat you, and carry no obligation to proceed.